BETA: Please send your feedback!
Rapid7
RPD:NAS
Information Technology Services
$2.62bn
SMALL cap
$53.55
(-1.50%)
0.70%
since start of 2019
-51.10
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 1
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 2002
Vanda Pharmaceuticals, Inc. is a global biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve the lives of patients. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
website
Headquarters
Executives
| Name | Title | Gender |
| Jeffrey A. Kalowski | Chief Financial Officer | Male |
| Christina M. Luconi | Chief People Officer | Female |
| Alan P. Matthews | Chairman | Male |
| Corey E. Thomas, MBA | President, Chief Executive Officer & Director | Male |
| Tas Giakouminakis | Chief Technical Officer | Male |
| Andrew Frank Burton, MBA | Chief Operating Officer | Male |
| Chad Loder | Founder | Male |
| Peter Kaes | Secretary & General Counsel | Male |
| Jeff Bray | Vice President-Investor Relations | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 1
Vanda Pharmaceuticals - Competitors and Related Companies
How Vanda Pharmaceuticals stacks up to its peers in the Biotechnology industry or with competing business segments.
Vanda Pharmaceuticals
VNDA:NAS
Biotechnology
$771.41mm
SMALL cap
$14.48
(-0.10%)
-0.47%
since start of 2019
26.82
Loading…